FreMon Scientific
FreMon Scientific develops biomedical platforms focused on dry, electronically controlled thawing of blood, plasma, and cell therapy products. Its core solutions include portable thawing devices and disposable thermal sleeves for optimized, contamination-reduced, and traceable thawing workflows. The systems are validated for regulatory compliance, supported by clinical studies, and utilized in hospitals, laboratories, and production settings globally.
Industries
N/A
FreMon Scientific is currently seeking investment
FreMon Scientific is seeking a series-a investment in the range of 5m-20m
Patents
Products
Portable, electronic device for rapid, waterless thawing of blood, plasma, and cell therapy materials featuring integrated data capture, traceability, large touch screen, ergonomic handle, and advanced barcode reader.
Patented, leak-proof disposable sleeve that accommodates various bag or vial sizes, designed for protection of biologic material during dry thawing, improved ease of loading, and further minimizes cross contamination risk.
Portable, electronic device for rapid, waterless thawing of blood, plasma, and cell therapy materials featuring integrated data capture, traceability, large touch screen, ergonomic handle, and advanced barcode reader.
Patented, leak-proof disposable sleeve that accommodates various bag or vial sizes, designed for protection of biologic material during dry thawing, improved ease of loading, and further minimizes cross contamination risk.
Expertise Areas
- Blood product management
- Biologics thawing
- Clinical laboratory automation
- Transfusion medicine technologies
Key Technologies
- Dry electronic thawing technology
- Temperature sensing and monitoring
- Disposable leak-proof thermal sleeves
- Automated process control and documentation
Key People
News & Updates
Examines inefficiencies, contamination risk, and operating costs associated with traditional water bath-based thawing methods in clinical settings.
A clinical evaluation with Comprehensive Cell Solutions demonstrated that the dry thawing device enables equivalent or superior cell viability and recovery compared to water bath thawing, with workflow and contamination control advantages.
Validation study presented at the International Society for Cell & Gene Therapy meeting showing dry thawing technology performance in cell therapy workflows.
Demonstration of advanced thawing capabilities at the ADS Warrior West trade show in San Diego, highlighting portability and ease of use.
University research accepted by ISCT highlighting that the dry thawing platform delivers operator-independent, reproducible thawing with controlled endpoints.
Partnership with the San Diego Blood Bank and New York Blood Center to guide continuous quality improvement, user training, and product testing.
Examines inefficiencies, contamination risk, and operating costs associated with traditional water bath-based thawing methods in clinical settings.
A clinical evaluation with Comprehensive Cell Solutions demonstrated that the dry thawing device enables equivalent or superior cell viability and recovery compared to water bath thawing, with workflow and contamination control advantages.
Validation study presented at the International Society for Cell & Gene Therapy meeting showing dry thawing technology performance in cell therapy workflows.
Demonstration of advanced thawing capabilities at the ADS Warrior West trade show in San Diego, highlighting portability and ease of use.
University research accepted by ISCT highlighting that the dry thawing platform delivers operator-independent, reproducible thawing with controlled endpoints.
Partnership with the San Diego Blood Bank and New York Blood Center to guide continuous quality improvement, user training, and product testing.